Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT04625595
Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 9, 2020
Completion: Jul 31, 2021